Walleye Capital’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-203,554	Closed	-$949K	–	2677
2021 Q4	$949K	Buy	203,554 +96,356	+90%	+$449K	0.03%	617
2021 Q3	$912	Buy	107,198 +90,763	+552%	+$772	0.03%	477
2021 Q2	$270	Buy	+16,435	New	+$270	0.01%	961